<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02088606</url>
  </required_header>
  <id_info>
    <org_study_id>VP-002 527 Version H</org_study_id>
    <nct_id>NCT02088606</nct_id>
  </id_info>
  <brief_title>TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Continued Access Protocol</brief_title>
  <official_title>TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Continued Access Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, multicenter, interventional study to collect confirmatory evidence on the
      safety and effectiveness of the TactiCath® percutaneous ablation catheter for the treatment
      of symptomatic paroxysmal atrial fibrillation using contact force assisted irrigated
      radiofrequency ablation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Electrical isolation of all 4 PVs, or in the event of a common PV, the clinical equivalent of all PVs, by the end of index procedure</measure>
    <time_frame>30 min post ablation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Acute procedural success and freedom from recurrence of symptomatic AF, AFL, and AT lasting longer than 30 seconds through 9 months of follow-up after a 3 month blanking period. Re-treatment for AF with ablation after 3 months is a failure</measure>
    <time_frame>12 months post ablation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Device-related early onset primary SAEs occurring within 7 days of the index procedure</measure>
    <time_frame>7 days post ablation</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">69</enrollment>
  <condition>Paroxysmal Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>TactiCath Quartz</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TactiCath Quartz treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TactiCath Quartz treatment</intervention_name>
    <description>Catheter ablation for the treatment of paroxysmal atrial fibrillation</description>
    <arm_group_label>TactiCath Quartz</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  symptomatic PAF (Paroxysmal Atrial Fibrillation)refractory to at least one Class I-IV
             antiarrhythmic drug

          -  minimum one documented PAF episode &gt;30 sec duration within prior 12 months

          -  minimum three PAF episodes during prior 12 months

          -  18 years or older

        Exclusion Criteria:

          -  persistent or long-standing persistent AF(Atrial Fibrillation)

          -  four or more cardioversions in prior 12 months

          -  MI (myocardial infarction), CABG (coronary artery bypass graft) or PCI (percutaneous
             coronary intervention) within preceding 3 months

          -  left atrial diameter &gt; 5.0 cm

          -  LVEF (left ventricular ejection fraction)&lt; 35%

          -  NYHA (New York Heart Association) class III or IV

          -  previous left atrial ablation procedure

          -  previous tricuspid or mitral valve repair surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vivek Reddy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2014</study_first_submitted>
  <study_first_submitted_qc>March 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2014</study_first_posted>
  <last_update_submitted>January 5, 2016</last_update_submitted>
  <last_update_submitted_qc>January 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

